20059 ⎘
Medicinal preparations characterised by special physical form; Dispersions; Emulsions; Emulsions ; Emulsion preconcentrates; Micelles Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
Stable micelles of fatty acid esters for the treatment of cardiovascular disease
#1502Nasal vaccine against the development of atherosclerosis disease and fatty liver
#1503Solid oral dosage form of testosterone derivative
#1504Functional foods and kits containing stable micelles of fatty acid esters
#1505Stable micelles of fatty acid esters
#1506Stable micelles of mixed fatty acids
#1507Method of preparing composition for delivering an anionic drug
#1508C-C-acylated derivative of hyaluronic acid and method of preparation thereof
#1509Self micro-emulsifying drug delivery system with increased bioavailability
#1510Microencapsulated nitrification inhibitor composition
#1511Stable pharmaceutical composition
#1512Compositions for Delivering Drugs with Low Water Solubility
#1513Phospholipid depot
#1514Formulations and carrier systems including compound interactive domains
#1515Saponin nano micelle, preparing method, application and pharmaceutical composition thereof
#1516Sustained-release lipid pre-concentrate of GNRH analogues and pharmaceutical composition comprising the same
#1517Pharmaceutical composition used for reducing damage caused by free radicals
#1518Activated nitric oxide donors and methods of making and using thereof
#1519Ophthalmic composition comprising a prostaglandin
#1520PREPARATION METHOD OF POLYMERIC MICELLES COMPOSITION CONTAINING A POORLY WATER-SOLUBLE DRUG
#1521Amphiphilic block copolymer and preparation method thereof and micellar drug-loading system formed by same with antitumor drug
#1522Self-emulsifying composition of ω3 fatty acid
#1523Methylene blue nanoparticle for bioimaging and photodynamic therapy and use thereof
#1524Method of making oil-in-oil emulsified polymeric implants containing a hypotensive lipid
#1525Modified RSV F proteins and methods of their use
#1526Fatty Acid Acylated D-Amino Acids for Oral Peptide Delivery
#1527Modified RSV F proteins and methods of their use
#1528Stable aqueous formulation of (E)-4-carboxystyryl-4-chlorobenzyl sulfone
#1529Nanosuspension of a poorly soluble drug via microfluidization process
#1530Nanoemulsion for transdermal delivery and method of making the same
#1531Compositions containing cyclic peptides and methods of use
#1532ARRANGING INTERACTION AND BACK PRESSURE CHAMBERS FOR MICROFLUIDIZATION
#1533Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using the same
#1534Microemulsion and sub-micron emulsion process and compositions
#1535Formulation for the Delivery of Nucleotide Sequences That Can Modulate Endogenous Interfering RNA Mechanisms
#1536Multicomponent degradable cationic polymers
#1537Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug
#1538Chelating amphiphilic polymers
#1539Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
#1540Asymmetric ionizable cationic lipid for RNA delivery
#1541Formulations and carrier systems including farnesylthiosalycylic moities
#1542CASEIN MICELLES FOR NANOENCAPSULATION OF HYDROPHOBIC COMPOUNDS
#1543Compositions for nanoemulsion delivery systems
#1544ORAL FORMULATIONS OF CHEMOTHERAPEUTIC AGENTS
#1545Treatment of skin, including aging skin, to improve appearance
#1546Parenteral compositions of celecoxib
#1547Compositions for the delivery of RNA and drugs into cells
#1548Polypeptide and lipophilic moiety conjugate compositions, formulations, and uses related thereto
#1549Nanoemulsion therapeutic compositions and methods of using the same
#1550Process for the production of a submicron oil in water emulsion
#1551ENCAPSULATION OF IMMISCIBLE PHASES IN SILK FIBROIN BIOMATERIALS
#1552Polymer-polymer composite nanoassemblies and applications thereof
#1553Topical Drug Delivery System for Ophthalmic Use
#1554ENHANCED BRAIN BIOAVAILABILITY OF GALANTAMINE BY SELECTED FORMULATIONS AND TRANSMUCOSAL ADMINISTRATION OF LIPOPHILIC PRODRUGS
#1555Water-soluble lipophilic natural compound formulations
#1556Microemulsion preconcentrates and microemulsions, and preparation processes of the same
#1557TOPICAL FORMULATIONS AND USES THEREOF
#1558Oral pharmaceutical formulation of BCS class III molecules
#1559Self-emulsifying pharmaceutical compositions of rhein or diacerein
#1560Ophthalmic compositions
#1561Microemulsions and uses thereof as nanoreactors or delivery vehicles
#1562Enzyme delivery systems and methods of preparation and use
#1563Mineral supplementation of beverages
#1564COMPOSITIONS FOR INACTIVATING PATHOGENIC MICROORGANISMS, METHODS OF MAKING THE COMPOSITIONS, AND METHODS OF USE THEREOF
#1565Micelle structure of nano preparation for diagnosis or treatment of cancer disease and preparation method thereof
#1566Progesterone formulations
#1567Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection
#1568Compositions of jasmonate compounds and methods of use
#1569Nanoemulsions
#1570Omega-3 Fatty Acid Ester Compositions
#1571Omega-3 Fatty Acid Ester Compositions
#1572Lipid nanocapsules comprising a retinoid, nanodispersion and composition containing the same, process for preparing the same and use thereof in dermatology
#1573Cyclosporine-containing non-irritative nanoemulsion ophthalmic composition
#1574Pharmaceutical dosage forms comprising 6′-fluoro-(N-methyl- or N,N-dimethyl-)-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine
#1575Cancer therapeutics
#1576Nanoparticle Formulations in Biomarker Detection
#1577Bolaamphiphilic compounds, compositions and uses thereof
#1578IN SITU GEL LOADED WITH PHOSPHODIESTERASE TYPE V INHIBITORS NANOEMULSION
#1579Block copolymer, liquid composite thereof, nucleic acid preparation, preparation methods therefor, and use thereof
#1580ANTI-OXIDANT SYNERGY FORMULATION NANOEMULSIONS TO TREAT CANCER
#1581Exopolysaccharide for the treatment and/or care of the skin, mucous membranes and/or nails
#1582Polylactide compositions and uses thereof
#1583Methods and compositions for administration of TRPV1 agonists
#1584Formulations for targeted release of agents to low pH tissue environments or cellular compartments and methods of use thereof
#1585Highly bioavailable, water soluble and sustained release nanoformulations hydrophobic plant derived compounds and extracts
#1586CYCLIC PEG COATINGS INCREASE THE BLOOD CIRCULATION TIME OF PARTICLES USED IN DRUG DELIVERY APPLICATIONS
#1587EMBELIN-BASED DELIVERY SYSTEM FOR WATER-INSOLUBLE ACTIVE AGENTS
#1588Method for treatment of pain and inflammation
#1589Reverse micelle system comprising nucleic acids and use thereof
#1590Reversibly crosslinked micelle systems
#1591Pomegranate oil for preventing and treating neurodegenerative diseases
#1592pH-Responsive High-Density Lipoprotein-Like Particle Complex
#1593Formulas for diagnosing and treating hormone-dependent cancers and cancers of the organs responsible for steroid hormone synthesis
#1594Self-preserved oil dispersions comprising boric acid
#1595Nutraceuticals having sustained release for improved bioavailability and method of production
#1596Arranging interaction and back pressure chambers for microfluidization
#1597Hormone containing emulsion
#1598Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity
#1599COMPOSITION FOR TRANSDERMAL DELIVERY AND METHODS THEREOF
#1600LECITHIN-ORGANOGELLING AGENT
#1601Polymer conjugated protein micelles
#1602Erythrocyte-binding therapeutics
#1603siRNA conjugate and preparation method thereof
#1604Omega-3 fatty acid ester compositions
#1605Omega-3 fatty acid ester compositions
#1606Robust controlled-release formulations
#1607Macrolide particulates, methods for preparation, and medical devices associated therewith
#1608Trolox derivative-modified fat-soluble anti-cancer pharmaceutical compounds, preparations, preparing methods and use thereof
#1609Enzymatic synthesis of poly(amine-co-esters) and methods of use thereof for gene delivery
#1610STABLE NANOEMULSIONS USEFUL IN THE TREATMENT OF CANCER
#1611Sustained-release nucleic acid matrix compositions
#1612Robust controlled-release peptide formulations
#1613Methods for forming miniemulsions and use thereof for delivering bioactive agents
#1614NANOPARTICLE THERAPEUTIC AGENTS, THEIR FORMULATIONS, AND METHODS OF THEIR USE
#1615Nanoparticles and nanoparticle compositions
#1616Cannabinoid formulations
#1617Immunogenic compositions and methods therefor
#1618Pesticidal compounds
#1619Nanoparticle compositions for generation of regulatory T cells and treatment of autoimmune diseases and other chronic inflammatory conditions
#1620Pharmaceutical compositions of hydrophobic camptothecin derivatives
#1621Modified RSV F proteins and methods of their use
#1622Multifunctional micellar nanoparticle-based drug and targeting agent system
#1623Nanoemulsion therapeutic compositions and methods of using the same
#1624Treatment method and product for uterine fibroids using purified collagenase
#1625Use of an Omega-3 Lipid-Based Emulsion Following Ischemic Injury to Provide Protection and Recovery in Human Organs
#1626Product and method for improving bioavailability of therapeutic compounds
#1627Microemulsion topical delivery platform
#1628RACECADOTRIL LIPID COMPOSITIONS
#1629Topical compositions of flunisolide and methods of treatment
#1630Racecadotril lipid compositions
#1631Treatment method and product for uterine fibroids using purified collagenase
#1632Formulations of water-soluble derivatives of vitamin E and compositions containing same
#1633Wax foamable vehicle and pharmaceutical compositions thereof
#1634Stable liquid formulations of volatile gas anesthetics
#1635WHEY PROTEIN MICELLES TO ENHANCE MUSCLE MASS AND PERFORMANCE
#1636Pharmaceutical Compositions for Oral Administration of Insulin Peptides
#1637STEROID HORMONE DELIVERY SYSTEMS AND METHODS OF PREPARING THE SAME
#1638CYCLOSPORIN ANALOG FORMULATIONS
#1639Method for preparation of a controlled release system
#1640Pharmaceutical composition on the basis of nanomicelles containing epigallocatechin gallate and a method of administration thereof to treat atopic dermatitis, Crohn's disease, adenomyosis, and hyperplastic diseases of the prostate gland
#1641Topical dermal delivery compositions using self assembling nanoparticles with cetylated components
#1642Method of Treating Skin Disorders using Nanoscale Delivery Devices and Transdermal Enhancing Compositions
#1643Stable pharmaceutical composition of clopidogrel free base for oral and parenteral delivery
#1644Propofol formulations with non-reactive container closures
#1645Cationic oil-in-water emulsions
#1646Dispersion anaesthetic device
#1647Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
#1648Controlled release method for a pharmaceutical composition composed of chelating complex micelles
#1649Sustained-release lipid pre-concentrate of pharmacologically active substance and pharmaceutical composition comprising the same
#1650BAB-type tri-block copolymer comprising polylactic acid (A) and polyethylene glycol (B), method for producing same, and drug delivery system using same
#1651Formulations and methods for treating dermatological disorders or diseases
#1652PH-SENSITIVE HYALURONIC ACID DERIVATIVE AND USES THEREOF
#1653Controlled release system
#1654Small molecule antagonists of phosphatidylinositol-3,4,5-triphosphate (PIP3) and uses thereof
#1655Method for treating sepsis in patients with albumin, cholesterol and HDL levels above minimum thresholds
#1656Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof
#1657Method for making nanolipidic particles
#1658Method for making nanolipidic particles
#1659IMMUNOTHERAPY FOR TREATMENT OF AMYLOID-RELATED DISORDERS USING ENCAPSULATED BETA-AMYLOID PEPTIDES
#1660Polymeric delivery systems for active agents
#1661Amphiphilic entity nanoparticles
#1662FORMULATION OF TRANSPARENT AND NUTRITIVE MICROEMULSIONS
#1663Hydrophobic Preparations
#1664Use of umirolimus and its derivatives for treating cancer
#1665Pharmaceutical emulsion compositions comprising progestogen
#1666Compositions for the treatment of rosacea
#1667Micellar Preparation Containing Sparingly Water-Soluble Anticancer Agent And Novel Block Copolymer
#1668Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes
#1669Branched amphipathic block polymer and molecular aggregate and drug delivery system using same
#1670Peptides useful in the treatment and care of the skin and mucous membranes and their use in cosmetic or pharmaceutical compositions
#1671Pharmaceutical semi-solid composition of isotretinoin
#1672THERAPEUTIC NANOEMULSION FORMULATION FOR THE TARGETED DELIVERY OF DOCETAXEL AND METHODS OF MAKING AND USING THE SAME
#1673Topical pharmaceutical composition based on semifluorinated alkanes
#1674Botulinum nanoemulsions
#1675Compositions and methods for localized drug delivery through mammary papillae
#1676Chemical composition with hydrogen peroxide and a nanoemulsion of long-chained alcohols
#1677Polypeptide based block copolymer and the process for the preparation thereof, and the polymer micelles using the same
#1678Pharmaceutical composition and methods for peptide treatment
#1679Nanolipidic particle assembly populations
#1680Polycarbonates bearing pendant primary amines for medical applications
#1681Self-emulsifying composition of OMEGA3 fatty acid
#1682Topical aqueous nanomicellar, ophthalmic solutions and uses thereof
#1683Nanocapsulation of essential oils for preventing or curing infectious diseases alone or with an antibiotic
#1684Compositions and methods of delivery of pharmacological agents
#1685Compositions and methods of delivery of pharmacological agents
#1686Drug delivery compositions and methods
#1687Amphiphilic dendron-coils, micelles thereof and uses
#1688Composition for a topical ophthalmic clear colloidal liquid which undergoes a liquid-gel phase transition in the eye
#1689Block copolymer, micelle preparation, and anticancer agent containing the same as active ingredient
#1690Adjuvant nanoemulsions with phospholipids
#1691Adjuvant nanoemulsions with crystallisation inhibitors
#1692Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
#1693Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols
#1694Hypoxia-Targeted Polymeric Micelles For Cancer Therapy And Imaging
#1695Racecadotril lipid compositions
#1696O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES
#1697COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE COMPRISING EPA AND DHA IN FREE ACID FORM, A SURFACTANT, AND A STATIN
#1698Pharmaceutical composition
#1699Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug
#1700Immunogenic compositions
#1701Natural combination hormone replacement formulations and therapies
#1702PH-sensitive compositions for delivery of beta lapachone and methods of use
#1703Propofol formulations with non-reactive container closures
#1704pH sensitive carrier and preparation method thereof, and pH sensitive drug and pH sensitive drug composition each containing the carrier, and method for treating or preventing diseases using the same
#1705DRUG CARRIER AND PREPARATION METHOD THEREOF
#1706Medicament and System for the Percutaneous Preparation of Medicaments
#1707Pharmaceutical composition of taxoids
#1708Ternary mixture formulations
#1709Non-liposomal systems for nucleic acid delivery
#1710Exopolysaccharide for treatment or care of skin, mucous membranes, hair or nails
#1711Microemulsion and sub-micron emulsion process and compositions
#1712Drug Delivery Dispersion And Film Formed Therefrom
#1713Pharmaceutical compositions of anti-acne agents
#1714Block copolymers for stable micelles
#1715Topical pharmaceutical compositions containing nanodroplets for the treatment psoriasis
#1716Amphiphilic compounds
#1717Method for treatment of acne using pharmaceutical compositions of clindamycin
#1718Carrier for negatively charged drugs comprising a cationic lipid and a preparation method thereof
#1719NON-IMMUNOGENIC DELIVERY VEHICLE FOR BETA-, GAMMA-, AND DELTA-TOCOPHEROLS AND METHODS OF USING AND MAKING SAME
#1720Formulation For Hormonotherapy
#1721Cyclodextrin-based microemulsions, and dermatological uses thereof
#1722Compositions and methods of delivery of pharmacological agents
#1723Sugar-based surfactant microemulsions containing essential oils for cosmetic and pharmaceutical use
#1724Multiplexed supramolecular assemblies for non-viral delivery of genetic material
#1725Polymerized micelles for diagnosis
#1726Pharmaceutical compositions of curcumin
#1727Pharmaceutical semi-solid composition of isotretinoin
#1728SYSTEMS, METHODS, AND DEVICES FOR PLASMID GENE TRANSFECTION USING POLYMER-MODIFIED MICROBUBBLES
#1729Pharmaceutical composition for transcolonic absorption
#1730Process for the preparation of water-in-oil and oil-in-water nanoemulsions
#1731DUAL-MODAL IMAGING-GUIDED DRUG VEHICLE WITH ULTRASOUND-TRIGGERED RELEASE FUNCTION
#1732Parenteral formulations of elacytarabine derivatives
#1733Matrix composition for delivery of hydrophobic actives
#1734Polymeric micelles for drug delivery
#1735Water-soluble pharmaceutical composition comprising at least one therapeutically active substance having hydrophobic properties and at least one compound selected from among sialoglycosphingolipids, glycosphingolipids or a mixture of sialoglycosphingolipids and glycosphingolipids
#1736Microemulsions with adsorbed macromolecules and microparticles
#1737Veterinary dermatologic composition
#1738Vitamin E formulations of sulfamide NS3 inhibitors
#1739Nanoemulsion composition containing vitamin K
#1740Orally bioavailable lipid-based constructs
#1741Micelle encapsulation of a combination of therapeutic agents
#1742Pharmaceutical semi-solid composition of isotretinoin
#1743Sulforaphane stabilization
#1744ECTOPARASITICIDE-CONTAINING PREPARATION FOR SPONTANEOUS EMULSION FORMATION
#1745Circulation of components during homogenization of emulsions
#1746Functional, cross-linked nanostructures for tandem optical imaging and therapy
#1747Microemulsion preparation of high concentration propofol for anesthetic uses
#1748Hydrophilic filtration during manufacture of vaccine adjuvants
#1749Stable topical composition and a process for producing a stable topical composition
#1750Delivery systems for improving oral bioavailability of Fenobam, its hydrates, and salts
#1751Poly(ethylene oxide)-block-poly(ester) block copolymers
#1752Microemulsions and its use for preventing airway diseases
#1753Tocotrienol compositions
#1754SiRNA conjugate and preparation method thereof
#1755Compositions of jasmonate compounds
#1756PROCESS FOR THE PREPARATION OF O/W EMULSION
#1757Multi-block copolymers for the preparation of stabilized micelles
#1758Reverse micelle system comprising nucleic acids and use thereof
#1759Nanoemulsion respiratory syncytial virus (RSV) subunit vaccine
#1760PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION OF INSULIN PEPTIDES
#1761Reverse micelle system comprising metal ions and use thereof
#1762NON-AQUEOUS TAXANE PRO-EMULSION FORMULATIONS AND METHODS OF MAKING AND USING THE SAME
#1763Methods of manufacturing viscous liquid pharmaceutical formulations
#1764Herpes simplex virus nanoemulsion vaccine
#1765STEROID HORMONE DELIVERY SYSTEMS AND METHODS OF PREPARING THE SAME
#1766EMULSIONS FOR TRANSDERMAL DELIVERY
#1767MEDICINAL COMPOSITIONS AND METHOD FOR TREATMENT OF URINARY TRACT INFECTIONS
#1768Non-Intravenous Dosage Form Comprising Solid Formulation of Liquid Biologically Active Agent and Uses Thereof
#1769Dermatological compositions comprising avermectin nanocapsules
#1770Dermatological, pharmaceutical composition suitable for oligonucleotides
#1771METHODS FOR REDUCING VEIN IRRITATION
#1772Isoxazolines for controlling invertebrate pests
#1773Topical compositions and methods of detection and treatment
#1774PHARMACEUTICAL DELIVERY SYSTEMS FOR HYDROPHOBIC DRUGS AND COMPOSITIONS COMPRISING SAME
#1775Compositions containing non-polar compounds
#1776Self-microemulsifying mitotane composition
#1777LIPID NANOPARTICLE CAPSULES
#1778Stable aqueous formulation of (E)-4-carboxystyryl-4-chlorobenzyl sulfone
#1779Antimicrobial polymers and methods of manufacture thereof
#1780Oil-in-water type nano-emulsion composition and method for preparing same
#1781Topical foam composition
#1782Human respiratory syncytial virus vaccine
#1783Topical foam composition
#1784MACROGOL 15 HYDROXYSTEARATE FORMULATIONS
#1785SUSTAINED DRUG RELEASE FROM BODY IMPLANTS USING NANOPARTICLE-EMBEDDED POLYMERIC COATING MATERIALS
#1786Anti-cancer agent delivery vehicles capable of improved loading
#1787Polymer particle delivery compositions and methods of use
#1788NANOPARTICLE COMPOSITIONS
#1789NANOPARTICLE COMPOSITIONS, FORMULATIONS THEREOF, AND USES THEREFOR
#1790NANOPARTICLE COMPOSITIONS AND COMPONENTS THEREOF
#1791ORAL MICROEMULSION OF ELEMENE
#1792CUTANEOUS COMPOSITION COMPRISING VITAMIN D ANALOGUE AND A MIXTURE OF SOLVENT AND SURFACTANTS
#1793Micelles for the solubilization of gossypol
#1794Compositions comprising superhydrophilic amphiphilic copolymers and methods of use thereof
#1795Methods and compositions for administration of TRPV1 agonists
#1796Micelle composition of polymer and passenger drug
#1797SUBMICRO EMULSION OF PACLITAXEL USING STEROID COMPLEX AS INTERMEDIATE CARRIER
#1798METHOD OF PRODUCING COATED FINE PARTICLES
#1799Sustained-release nucleic acid matrix compositions
#1800Solid Formulations of Liquid Biologically Active Agents